The Effect of Body Mass Index on Survival in Lung Cancer

References

• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Mattiuzzi C, Lippi G. Current Cancer Epidemiology. J Epidemiol Glob Health. 2019;9(4):217–22. doi:10.2991/jegh.k.191008.001
   PubMed Web of Science ®Google Scholar
• Lortet-Tieulent J, Renteria E, Sharp L, Weiderpass E, Comber H, Baas P, Bray F, Coebergh JW, Soerjomataram I. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010. Eur J Cancer. 2015;51(9):1144–63. doi:10.1016/j.ejca.2013.10.014
   PubMed Web of Science ®Google Scholar
• Johal S, Hettle R, Carroll J, Maguire P, Wynne T. Real-world treatment patterns and outcomes in small-cell lung cancer: a systematic literature review. J Thorac Dis. 2021;13(6):3692–707. doi:10.21037/jtd-20-3034
   PubMed Web of Science ®Google Scholar
• Lu T, Yang X, Huang Y, Zhao M, Li M, Ma K, Yin J, Zhan C, Wang Q. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019;11:943–53. doi:10.2147/CMAR.S187317
   PubMed Web of Science ®Google Scholar
• Rawson NSB, Peto J. An overview of prognostic factors in small cell lung cancer. Br J Cancer. 1990;61(4):597–604. doi:10.1038/bjc.1990.133
   PubMed Web of Science ®Google Scholar
• Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, et al. A prognostic model for advanced stage nonsmall cell lung cancer. Cancer. 2006;107(4):781–92. doi:10.1002/cncr.22049
   PubMed Web of Science ®Google Scholar
• World Health Organization. A healthy lifestyle – WHO recommendations [accessed 2022 July 25]. https://www.who.int/europe/news-room/fact-sheets/item/a-healthy-lifestyle.–-whorecommendations
   Google Scholar
• Kenchaiah S, Evans JC, Levy D, Wilson PWF, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the Risk of Heart Failure. N Engl J Med. 2002;347(5):305–13. doi:10.1056/NEJMoa020245
   PubMed Web of Science ®Google Scholar
• Dahlberg SE, Schiller JH, Bonomi PB, Sandler AB, Brahmer JR, Ramalingam SS, Johnson DH. Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials. J Thorac Oncol. 2013;8(9):1121–7. doi:10.1097/JTO.0b013e31829cf942
   PubMed Web of Science ®Google Scholar
• Argolo DF, Hudis CA, Iyengar NM. The Impact of Obesity on Breast Cancer. Curr Oncol Rep. 2018;20(6):47. doi:10.1007/s11912-018-0688-8
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu Y, Shao H, Zheng X. Obesity paradox in lung cancer prognosis: evolving biological ınsights and clinical ımplications. J Thorac Oncol. 2017;12(10):1478–88. doi:10.1016/j.jtho.2017.07.022
   PubMed Web of Science ®Google Scholar
• Trestini I, Carbognin L, Bonaiuto C, Tortora G, Bria E. The obesity paradox in cancer: clinical insights and perspectives. Eat Weight Disord. 2018;23(2):185–93. doi:10.1007/s40519-018-0489-y
   PubMed Web of Science ®Google Scholar
• Banack HR, Stokes A. The ‘obesity paradox’ may not be a paradox at all. Int J Obes (Lond). 2017;41(8):1162–3. doi:10.1038/ijo.2017.99
   PubMed Web of Science ®Google Scholar
• Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, International Agency for Research on Cancer Handbook Working Group. Body fatness and cancer—viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794–8. doi:10.1056/NEJMsr1606602
   PubMed Web of Science ®Google Scholar
• Lajous M, Banack HR, Kaufman JS, Hernán MA. Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am J Med. 2015;128(4):334–6. doi:10.1016/j.amjmed.2014.10.043
   PubMed Web of Science ®Google Scholar
• Gupta A, Majumder K, Arora N, Mayo HG, Singh PP, Beg MS, Hughes R, Singh S, Johnson DH. Premorbid body mass index and mortality in patients with lung cancer: a systematic review and meta-analysis. Lung Cancer. 2016;102:49–59. doi:10.1016/j.lungcan.2016.10.017
   PubMed Web of Science ®Google Scholar
• Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O, Salati M, Dottorini L, Iaculli A, Varricchio A, et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw Open. 2021;4(3):e213520. doi:10.1001/jamanetworkopen.2021.3520
   PubMed Web of Science ®Google Scholar
• Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr. 2008;17(3):370–4
   PubMed Web of Science ®Google Scholar
• Shankar A, Saini D, Dubey A, Roy S, Bharati SJ, Singh N, Khanna M, Prasad CP, Singh M, Kumar S, et al. Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward. Transl Lung Cancer Res. 2019;8(S1):S106–S121. doi:10.21037/tlcr.2019.03.03
   PubMed Web of Science ®Google Scholar
• Toh CK. The changing epidemiology of lung cancer. Methods Mol Biol Clifton NJ. 2009;472:397–411. doi:10.1007/978-1-60327-492-0_19
   PubMedGoogle Scholar
• Finke I, Behrens G, Weisser L, Brenner H, Jansen L. Socioeconomic differences and lung cancer survival—systematic review and meta-analysis. Front Oncol. 2018;8:536
   PubMed Web of Science ®Google Scholar
• Wang J, Xu H, Zhou S, Wang D, Zhu L, Hou J, Tang J, Zhao J, Zhong S. Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis. Eur J Clin Nutr. 2018;72(1):4–17. doi:10.1038/ejcn.2017.70
   PubMed Web of Science ®Google Scholar
• Shepshelovich D, Xu W, Lu L, Fares A, Yang P, Christiani D, Zhang J, Shiraishi K, Ryan BM, Chen C, et al. Body Mass Index (BMI), BMI change, and overall survival in patients With SCLC and NSCLC: a pooled analysis of the ınternational lung cancer consortium. J Thorac Oncol. 2019;14(9):1594–607. doi:10.1016/j.jtho.2019.05.031
   PubMed Web of Science ®Google Scholar
• Tarleton HP, Park SL, Zhu W-M, Lee Y-CA, Hashibe M, Morgenstern H, Tashkin DP, Mao JT, Cozen W, Mack TM, et al. Body mass index change in adulthood and lung and upper aerodigestive tract cancers. Int J Cancer. 2012;131(6):1407–16. doi:10.1002/ijc.27383
   PubMed Web of Science ®Google Scholar
• Icard P, Schussler O, Loi M, Bobbio A, Mansuet Lupo A, Wislez M, Iannelli A, Fournel L, Damotte D, Alifano M, et al. Pre-Disease and pre-surgery BMI, weight loss and sarcopenia ımpact survival of resected lung cancer ındependently of tumor stage. Cancers. 2020;12(2):266. doi:10.3390/cancers12020266
   PubMed Web of Science ®Google Scholar
• Mondello P, Lacquaniti A, Mondello S, Bolignano D, Pitini V, Aloisi C, Buemi M. Emerging markers of cachexia predict survival in cancer patients. BMC Cancer. 2014;14(1):828. doi:10.1186/1471-2407-14-828
   PubMed Web of Science ®Google Scholar
• Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T, Hisamatsu Y, Tokito T, Imai H, Akamatsu H, et al. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer. 2015;23(6):1699–708. doi:10.1007/s00520-014-2534-2533
   PubMed Web of Science ®Google Scholar
• Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O'Brien MER. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer. 2004;90(10):1905–11. doi:10.1038/sj.bjc.6601781
   PubMed Web of Science ®Google Scholar
• Jiang M, Fares AF, Shepshelovich D, Yang P, Christiani D, Zhang J, Shiraishi K, Ryan BM, Chen C, Schwartz AG, et al. The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: a pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients. Lung Cancer. 2021;152:58–65. doi:10.1016/j.lungcan.2020.11.029
   PubMed Web of Science ®Google Scholar
• Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9. doi:10.3322/caac.21388
   PubMed Web of Science ®Google Scholar
• Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015;191(1):19–33. doi:10.1164/rccm.201410-1777CI
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. In: Ahmad A, Gadgeel S, editors. Lung cancer and therapies (Advances in Experimental Medicine and Biology). Cham: Springer International Publishing; 2016. pp. 1–19. Available from: doi:10.1007/978-3-319-24223-1_1
   Google Scholar
• Gülhan M, Yilmaz YA. Early diagnosis and screening in lung cancer. In: Ünsal M, editor. Lung Cancer. vol. 13. Ankara: Türkiye Klinikleri; 2020. pp. 6–11
   Google Scholar
• National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. doi:10.1056/NEJMoa1102873
   PubMed Web of Science ®Google Scholar
• Turkish Public Health Institution Cancer Department. Akciğer Kanseri Çalıştayı Sonuç Raporu [accessed 2022 January 20]. https://hsgm.saglik.gov.tr/depo/birimler/kanserdb/yayinlar/raporlar/Akciger_Kanseri_Calistay_Raporu28042016.pdf
   Google Scholar
• Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D’Amico TA, D’Avella C, Dowlati A, Downey RJ, Edelman M, et al. Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(12):1441–64. doi:10.6004/jnccn.2021.0058
   PubMed Web of Science ®Google Scholar
• Cuffe S, Moua T, Summerfield R, Roberts H, Jett J, Shepherd FA. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers. J Thorac Oncol. 2011;6(4):818–22. doi:10.1097/JTO.0b013e31820c2f2e
   PubMed Web of Science ®Google Scholar
• Barquín M, Calvo V, García-García F, Nuñez B, Sánchez-Herrero E, Serna-Blasco R, Auglytė M, Carcereny E, Rodriguez-Abreu D, López Castro R, et al. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation. Cancer Epidemiol. 2020;67:101737. doi:10.1016/j.canep.2020.101737
   PubMed Web of Science ®Google Scholar
• Çetingöz R, Demiral AN. Radiotherapy in non-small cell lung cancers. Turkiye Klinikleri J Pulm Med-Special Topics. 2020;13(2):43–7
   Google Scholar
• Senkus-Konefka E, Dziadziuszko R, Bednaruk-Młyński E, Pliszka A, Kubrak J, Lewandowska A, Małachowski K, Wierzchowski M, Matecka-Nowak M, Jassem J, et al. A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC). Br J Cancer. 2005;92(6):1038–45. doi:10.1038/sj.bjc.6602477
   PubMed Web of Science ®Google Scholar
• Foster NR, Mandrekar SJ, Schild SE, Nelson GD, Rowland KM, Deming RL, Kozelsky TF, Marks RS, Jett JR, Adjei AA, et al. Prognostic factors differ by tumor stage for small cell lung cancer. Cancer. 2009;115(12):2721–31. https:// doi:10.1002/cncr.24314
   PubMed Web of Science ®Google Scholar
• SEER*Explorer Application. [accessed 2022 August 5]. https://seer.cancer.gov/statistics-network/explorer/application.html?site=611&data_type=4&graph_type=5&compareBy=age_range&chk_age_range_1=1&chk_age_range_9=9&chk_age_range_141=141&chk_age_range_157=157&series=9&sex=1&race=1&stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_display=2#graphArea
   Google Scholar
• Tas F, Ciftci R, Kilic L, Karabulut S. Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett. 2013;6(5):1507–13. doi:10.3892/ol.2013.1566
   PubMed Web of Science ®Google Scholar
• Ludbrook JJ, Truong PT, MacNeil MV, Lesperance M, Webber A, Joe H, Martins H, Lim J. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis. Int J Radiat Oncol. 2003;55(5):1321–30. doi:10.1016/S0360-3016(02)04576-5
   PubMed Web of Science ®Google Scholar
• Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. In lung cancer patients, age, race-ethnicity, gender and smoking predict adverse comorbidity, which in turn predicts treatment and survival. J Clin Epidemiol. 2004;57(6):597–609. doi:10.1016/j.jclinepi.2003.11.002
   PubMed Web of Science ®Google Scholar
• Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB. How do patient and hospital features influence outcomes in small-cell lung cancer in England? Br J Cancer. 2011;105(6):746–52. doi:10.1038/bjc.2011.310
   PubMed Web of Science ®Google Scholar
• Bahij R, Jeppesen SS, Olsen KE, Halekoh U, Holmskov K, Hansen O. Outcome of treatment in patients with small cell lung cancer in poor performance status. Acta Oncol. 2019;58(11):1612–7. doi:10.1080/0284186X.2019.1637934
   PubMed Web of Science ®Google Scholar
• Ganti AK, Loberiza FR, Kessinger A. Association of positive family history with survival of patients with lung cancer. Lung Cancer. 2009;63(1):136–9. doi:10.1016/j.lungcan.2008.04.008
   PubMed Web of Science ®Google Scholar
• Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer. 2005;93(7):825–33. doi:10.1038/sj.bjc.6602769
   PubMed Web of Science ®Google Scholar
• Aarts MJ, Aerts JG, van den Borne BE, Biesma B, Lemmens VEPP, Kloover JS. Comorbidity in patients with small-cell lung cancer: trends and prognostic ımpact. Clin Lung Cancer. 2015;16(4):282–91. doi:10.1016/j.cllc.2014.12.003
   PubMed Web of Science ®Google Scholar
• Li N, Shao K, Chen Z, Qiu B, Wang Z, Tan F, Wang J, Tan X, Li B, Xiong M, et al. The impact of positive cancer family history on the clinical features and outcome of patients with non-small cell lung cancer. Fam Cancer. 2011;10(2):331–6. doi:10.1007/s10689-010-9403-0
   PubMed Web of Science ®Google Scholar
• Takahashi N, Tlemsani C, Pongor L, Rajapakse V, Tyagi M, Wen X, Fasaye G, Schmidt K, Kim C, Rajan A, et al. OA11.05 whole exome sequencing reveals the potential role of hereditary predisposition in small cell lung cancer, a tobacco-related cancer. J Thorac Oncol. 2021;16(3):S127–S128. doi:10.1016/j.jtho.2021.01.315
   PubMed Web of Science ®Google Scholar